BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 821837)

  • 41. [Progress in the diagnosis, therapy and prevention of morbus hemolyticum neonatorum].
    Kintzel HW
    Z Arztl Fortbild (Jena); 1968 Jun; 62(12):634-40. PubMed ID: 4971390
    [No Abstract]   [Full Text] [Related]  

  • 42. [Preventive care and prenatal therapy of hemolytic disease of newborn].
    Stamm H
    Ther Ggw; 1971 Nov; 110(11):1657-8 passim. PubMed ID: 5003495
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

  • 44. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 45. Rhesus disease: the model for fetal therapy.
    Nicolaides KH; Rodeck CH
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The problem of antibody control during the first days after anti-D prophylaxis].
    Ennker J; Maas DH; Schneider J
    Fortschr Med; 1978 Sep; 96(33):1650-6. PubMed ID: 100401
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hemolytic disease of the newborn due to rhesus incompatibility].
    von Criegern T
    Med Klin; 1979 Jun; 74(26):1013-22. PubMed ID: 111015
    [No Abstract]   [Full Text] [Related]  

  • 48. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].
    di Maria H; Parnet Mathieu F; Rio di Maria D; Maigret P; Gire R; Guillot F; Lasfargues G; Brossard Y
    Arch Fr Pediatr; 1990 Feb; 47(2):125-7. PubMed ID: 2158285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and therapy in fetuses at risk in Rh isoimmunization].
    Calda P; Zizka Z; Rezábek K; Masata J; Bendl J
    Cesk Gynekol; 1993 Dec; 58(6):278-82. PubMed ID: 8293503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of the Rh-negative mother.
    Beck RP
    Can Med Assoc J; 1973 Nov; 109(9):903-4. PubMed ID: 4127213
    [No Abstract]   [Full Text] [Related]  

  • 52. [An alternative method of treatment for the icteric-anemic form of neonatal iso-immunization to rhesus factor].
    Perepelitsa SA; Kashina NA; Sidorova NL
    Anesteziol Reanimatol; 2010; (1):60-2. PubMed ID: 20564941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Rhesus incompatible baby.
    Minns H
    Nurs Times; 1973 May; 69(21):668-70. PubMed ID: 4196277
    [No Abstract]   [Full Text] [Related]  

  • 54. [Physiopathology of Rh-prevention. Elimination of rhesus-positive radio-chromium labeled umbilical cord erythrocytes in rhesus-negative persons after application of anti-D-serums].
    Schneider J; Leidenberger H; Heimpel H
    Med Klin; 1970 Apr; 65(15):718-23. PubMed ID: 4108360
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prevention of rhesus sensitization using immunoglobulin G anti-D].
    Börner P; Deicher H
    Dtsch Med J; 1969 Aug; 20(15):471-6. PubMed ID: 4898976
    [No Abstract]   [Full Text] [Related]  

  • 56. [Rh sensitization].
    Drazancić A; Gorecan V; Barsić E
    Rad Med Fak Zagrebu; 1970; 18(2):89-105. PubMed ID: 4999735
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of severe Rhesus erythroblastosis].
    Bichler A; Frisch H
    Padiatr Padol; 1977; 12(4):339-48. PubMed ID: 409979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 60. [Titers and hemolytic late effects of rhesus antibodies in exchange transfusion in newborn infants with hemolytic anemia due to the rhesus factor].
    Ruckstuhl J
    Helv Paediatr Acta; 1970 Jul; 25(3):258-72. PubMed ID: 4996413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.